{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:07:59Z","timestamp":1788545279525,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jpha.2024.101069","type":"journal-article","created":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T09:55:03Z","timestamp":1723974903000},"page":"101069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["New applications of clioquinol in the treatment of inflammation disease by directly targeting arginine 335 of NLRP3"],"prefix":"10.1016","volume":"15","author":[{"given":"Peipei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3310-0844","authenticated-orcid":false,"given":"Chao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Lin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2024.101069_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jpha.2024.101069_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpha.2024.101069_bib3","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jpha.2024.101069_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1109938","article-title":"The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors","volume":"13","author":"Zhan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2024.101069_bib5","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2024.101069_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer\u2019s disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.jpha.2024.101069_bib7","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00221-020-05916-6","article-title":"Protection of MCC950 against Alzheimer\u2019s disease via inhibiting neuronal pyroptosis in SAMP8 mice","volume":"238","author":"Li","year":"2020","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.jpha.2024.101069_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2024.101069_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00203-022-03122-2","article-title":"Antimicrobial activity of clioquinol and nitroxoline: A scoping review","volume":"204","author":"Wykowski","year":"2022","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.jpha.2024.101069_bib10","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jpha.2024.101069_bib11","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","article-title":"Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington\u2019s disease mouse model","volume":"102","author":"Nguyen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpha.2024.101069_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4264-2","article-title":"Radio sensitization of clioquinol and zinc in human cancer cell lines","volume":"18","author":"Lu","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jpha.2024.101069_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110268","article-title":"Clioquinol induces autophagy by down-regulation of calreticulin in human neurotypic SH-SY5Y cells","volume":"369","author":"Lv","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpha.2024.101069_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-2008-15208","article-title":"Drug development based on the metal\u2019s hypothesis of Alzheimer\u2019s disease","volume":"15","author":"Bush","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpha.2024.101069_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02682-w","article-title":"Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases","volume":"19","author":"Chen","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpha.2024.101069_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105748","article-title":"Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4\/NLRP3\/GSDMD-dependent pyroptosis","volume":"170","author":"Yuan","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jpha.2024.101069_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jpha.2024.101069_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jpha.2024.101069_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146852","article-title":"NLRP3\/caspase-1\/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression","volume":"6","author":"Li","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpha.2024.101069_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","article-title":"Drug affinity responsive target stability (DARTS) for small-molecule target identification","volume":"1263","author":"Pai","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpha.2024.101069_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/science.aas8995","article-title":"HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation","volume":"369","author":"Magupalli","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jpha.2024.101069_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10753-019-01124-9","article-title":"The NLRP3 inflammasome and its role in sepsis development","volume":"43","author":"Danielski","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.jpha.2024.101069_bib23","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.jpha.2024.101069_bib24","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2009.197822","article-title":"Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome","volume":"59","author":"Bauer","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jpha.2024.101069_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/db12-0420","article-title":"Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes","volume":"62","author":"Lee","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jpha.2024.101069_bib26","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2024.101069_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/bpa.12477","article-title":"Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)","volume":"27","author":"Barclay","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jpha.2024.101069_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01842-0","article-title":"Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice","volume":"17","author":"Dong","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jpha.2024.101069_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1474-4422(14)70262-5","article-title":"Safety, tolerability, and efficacy of PBT2 in Huntington\u2019s disease: A phase 2, randomised, double-blind, placebo-controlled trial","volume":"14","author":"Investigators","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpha.2024.101069_bib30","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","article-title":"Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: Implications for Parkinson disease","volume":"15","author":"Han","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.jpha.2024.101069_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115735","article-title":"The interplay between alpha-Synuclein and NLRP3 inflammasome in Parkinson\u2019s disease","volume":"168","author":"Huang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpha.2024.101069_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1515\/acph-2015-0034","article-title":"Induction of cell cycle arrest via the p21, p27-cyclin E, A\/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol","volume":"65","author":"Huang","year":"2015","journal-title":"Acta Pharm"},{"key":"10.1016\/j.jpha.2024.101069_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and autophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpha.2024.101069_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1623","article-title":"Tau induces inflammasome activation and microgliosis through acetylating NLRP3","volume":"14","author":"Zhang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jpha.2024.101069_bib35","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1016\/j.molcel.2023.11.015","article-title":"ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation","volume":"83","author":"Zheng","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jpha.2024.101069_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41423-023-01121-x","article-title":"Nuclear receptor coactivator 6 is a critical regulator of NLRP3 inflammasome activation and gouty arthritis","volume":"21","author":"Lee","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jpha.2024.101069_bib37","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/s41401-023-01105-7","article-title":"Theaflavin mitigates acute gouty peritonitis and septic organ injury in mice by suppressing NLRP3 inflammasome assembly","volume":"44","author":"Chen","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpha.2024.101069_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpha.2024.101069_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2024.101069_bib40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41401-023-01212-5","article-title":"Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice","volume":"45","author":"Shao","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpha.2024.101069_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134601","article-title":"Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90","volume":"6","author":"Xu","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpha.2024.101069_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-023-00671-0","article-title":"Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC","volume":"29","author":"Zhao","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.jpha.2024.101069_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1028575","article-title":"Intra-articular injection of clioquinol ameliorates osteoarthritis in a rabbit model","volume":"9","author":"Wu","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jpha.2024.101069_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02566","article-title":"The role of NLRP3 and IL-1\u03b2 in the pathogenesis of inflammatory bowel disease","volume":"9","author":"Mao","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177924001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:29:11Z","timestamp":1740634151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177924001667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2095177924001667"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101069","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New applications of clioquinol in the treatment of inflammation disease by directly targeting arginine 335 of NLRP3","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101069"}}